Search research articles
Contact Us
Filters
Showing results (21-30 of 115) with videos related to
Page
of 12
Sort By:
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 17, 2009
Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress
Francis Rodriguez Bambico, Nhu-Tram Nguyen, Gabriella Gobbi
Journal of Clinical Psychopharmacology
|
February 28, 2012
The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium
Stefano Comai, Michael Tau, Zoran Pavlovic, et al.
Frontiers in Pharmacology
|
February 18, 2022
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
Athanasios Markopoulos, Antonio Inserra, Danilo De Gregorio, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 26, 2007
Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex
Francis Rodriguez Bambico, Noam Katz, Guy Debonnel, et al.
Current Medicinal Chemistry
|
February 11, 2017
Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain
Luca Posa, Danilo De Gregorio, Gabriella Gobbi, et al.
International Journal of Molecular Sciences
|
November 26, 2016
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
Danilo De Gregorio, Stefano Comai, Luca Posa, et al.
Journal of Clinical Psychopharmacology
|
November 4, 2021
Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital
Stefano Comai, Yves Fuamba, Maria Chiara Rivolta, et al.
CNS Drugs
|
August 21, 2023
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
Antonio Inserra, Alexandre Piot, Danilo De Gregorio, et al.
Journal of Clinical Psychopharmacology
|
June 27, 2003
Neurochemical and psychotropic effects of bupropion in healthy male subjects
Gabriella Gobbi, Susan Slater, Nathalie Boucher, et al.
The International Journal of Neuropsychopharmacology
|
February 15, 2022
Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression
Christophe Moderie, Nicolas Nuñez, Allan Fielding, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 115) with videos related to
Sort By:
Page
of 12
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
January 17, 2009
Decline in serotonergic firing activity and desensitization of 5-HT1A autoreceptors after chronic unpredictable stress
Francis Rodriguez Bambico, Nhu-Tram Nguyen, Gabriella Gobbi
Journal of Clinical Psychopharmacology
|
February 28, 2012
The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium
Stefano Comai, Michael Tau, Zoran Pavlovic, et al.
Frontiers in Pharmacology
|
February 18, 2022
Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder
Athanasios Markopoulos, Antonio Inserra, Danilo De Gregorio, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
|
October 26, 2007
Cannabinoids elicit antidepressant-like behavior and activate serotonergic neurons through the medial prefrontal cortex
Francis Rodriguez Bambico, Noam Katz, Guy Debonnel, et al.
Current Medicinal Chemistry
|
February 11, 2017
Targeting Melatonin MT2 Receptors: A Novel Pharmacological Avenue for Inflammatory and Neuropathic Pain
Luca Posa, Danilo De Gregorio, Gabriella Gobbi, et al.
International Journal of Molecular Sciences
|
November 26, 2016
d-Lysergic Acid Diethylamide (LSD) as a Model of Psychosis: Mechanism of Action and Pharmacology
Danilo De Gregorio, Stefano Comai, Luca Posa, et al.
Journal of Clinical Psychopharmacology
|
November 4, 2021
Lifetime Cannabis Use Disorder Is Not Associated With Lifetime Impulsive Behavior and Severe Violence in Patients With Schizophrenia Spectrum Disorders From a High-Security Hospital
Stefano Comai, Yves Fuamba, Maria Chiara Rivolta, et al.
CNS Drugs
|
August 21, 2023
Lysergic Acid Diethylamide (LSD) for the Treatment of Anxiety Disorders: Preclinical and Clinical Evidence
Antonio Inserra, Alexandre Piot, Danilo De Gregorio, et al.
Journal of Clinical Psychopharmacology
|
June 27, 2003
Neurochemical and psychotropic effects of bupropion in healthy male subjects
Gabriella Gobbi, Susan Slater, Nathalie Boucher, et al.
The International Journal of Neuropsychopharmacology
|
February 15, 2022
Sex Differences in Responses to Antidepressant Augmentations in Treatment-Resistant Depression
Christophe Moderie, Nicolas Nuñez, Allan Fielding, et al.
Page
of 12